New Zealand markets open in 8 hours 34 minutes

Ligand Pharmaceuticals Incorporated (LGND)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
87.28+1.16 (+1.35%)
At close: 04:00PM EDT
86.50 -0.78 (-0.89%)
Pre-market: 09:03AM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts4443
Avg. Estimate1.041.184.545.58
Low estimate0.941.074.485.39
High estimate1.171.314.645.84
Year ago EPS1.421.026.094.54
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts4454
Avg. Estimate32.82M35.54M138.15M160.73M
Low estimate30.5M33.31M134M153.8M
High estimate35.3M38.9M141.3M170M
Year ago salesN/AN/A131.31M138.15M
Sales growth (year/est)N/AN/A5.20%16.30%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS0.640.610.660.78
Actual EPS1.421.021.381.2
Difference0.780.410.720.42
Surprise %121.90%67.20%109.10%53.80%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate1.041.184.545.58
7 days ago1.031.214.445.6
30 days ago1.021.194.455.6
60 days ago1.021.194.455.6
90 days ago0.941.164.275.35
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days2131
Up last 30 days3231
Down last 7 daysN/AN/AN/AN/A
Down last 30 days12N/A1
Growth estimatesLGNDIndustrySector(s)S&P 500
Current qtr.-26.80%N/AN/AN/A
Next qtr.15.70%N/AN/AN/A
Current year-25.50%N/AN/AN/A
Next year22.90%N/AN/AN/A
Next 5 years (per annum)20.00%N/AN/AN/A
Past 5 years (per annum)12.40%N/AN/AN/A